Self-Management Behaviors of Arabs and Jews With Parkinson's Disease and Their Associations With Health Outcomes
NCT ID: NCT05209698
Last Updated: 2022-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2500 participants
OBSERVATIONAL
2021-05-15
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In the first part of the study, data will be extracted from electronic medical records of 2500. In the second part of the study, a sub-sample of 200 participants with Parkinson's disease will be asked to answer standardized questionnaires.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Socio-Clinical Factors Associated With Self-Management in Parkinson's Disease
NCT05211700
Consequences of the COVID-19 Lockdown on Health and Well-being of Patients With Parkinson Disease and Post-stroke
NCT04535297
Self-motion Perception in Parkinson's Disease
NCT03137238
Effect of Medical Cannabis for Non-motor Symptoms of Parkinson's Disease
NCT05106504
Computer-based Cognitive Training for Parkinson Disease
NCT01121627
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study objectives were: To (1) to identify the reciprocal relationships among extra- and intra-personal level determinants of Self-Management Behaviors and their association with performance of these behaviors in persons with Parkinson's Disease, (2) identify the relationships between self-management behaviors (medical and lifestyle), function, and quality of life in patients with Parkinson's Disease.
Phase A of the study is a retrospective study based on extraction and analysis of data from electronic medical records, and phase B of the study is a cross-sectional study based on face-to-face meetings with a subsample of the patients whose data are included in the retrospective study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ethnic groups- Jews and Arabs
Data will be extracted from electronic medical records for all people with PD residing in a specific HMO district according to a record-based survey (e.g., individuals whose medical records include a diagnosis of PD). Currently, there are 2500 patients with PD in that district. In the second part of the study, a sub-sample of 100 Jewish and 100 Arab Patients with Parkinson's disease will be asked to answer standardized questionnaires.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Jewish sector will be fluency in Hebrew (comprehension, speaking, and reading), and for the Arab sector, fluency in Arabic or Hebrew (comprehension, speaking, and reading).
Exclusion Criteria
2. Severe co-morbidities other than PD that affect daily living, special populations including pregnant women, minors (\<18 years old).
3. Patients who are not eligible to sign consent forms due to physical or mental conditions.
4. People who have a guardian, score less than 20 in the Mini-Mental state exam test.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clalit Health Services
OTHER
University of Haifa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michal Kafri, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Haifa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Haifa
Haifa, Aba Hushi, Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Naamneh-Abuelhija B, Kafri M, Kestenbaum M, Giveon S, Kamah S, Shved S, Yogev-Seligmann G. Concealment of Parkinsons disease prevalence and impact on health and quality of life. Sci Rep. 2025 Mar 4;15(1):7551. doi: 10.1038/s41598-025-91579-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0128-19-COM1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.